For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
How The No Surprises Act worsened the problem of surprise bills
Next week, Sen. Bill Cassidy (R-LA) will convene a roundtable to discuss adjustments to the 2020 No Surprises Act, which has come under…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Search Posts
Regulatory Transparency Project
AUDIO: Explainer Episode 48 – The FDA & the Practice of Medicine: Possible Regulation of Off-Label Prescriptions
Senior Fellow Joel Zinberg joins the Regulatory Transparency Project to discuss possibly regulation of off-label prescriptions: On December 29, 2022, President Biden signed…
Citation
FDA’s Medical Interference, Time for ESG Antitrust Action and other commentary
Libertarian: FDA’s Medical Interference The Wall Street Journal quoted Joel Zinberg on FDA banning practices: “Secreted within the 2023…
Wall Street Journal
The FDA Wants to Interfere in the Practice of Medicine
Secreted within the 2023 omnibus appropriations bill—4,155 pages, spending $1.7 trillion—is a 19-line section that could change the way medicine is practiced. Physicians…
City Journal
PODCAST: The Last Gasp of Pandemic Restrictions?
Senior Fellow Joel Zinberg joins Brian Anderson at City Journal to discuss the “tripledemic” of Covid, flu and RSV, the relationship of public health…
Blog
Omnibus Bill Throws More Money at CDC, Does Not Reform It
Congress has passed the $1.7 trillion fiscal 2023 omnibus appropriations bill. The 4,155-page legislation, which covers everything from agriculture to veterans, includes a…
City Journal
Ignore the “Tripledemic” Hype
Winter is back, and so are warnings from “experts” for Americans to don masks. A resurgence of influenza (flu) and respiratory syncytial virus (RSV)—respiratory…